PUMA BIOTECHNOLOGY, INC. (PBYI) Capital expenditures 2016–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$71,000FY2025 · since FY2016: $4.3M → $71,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $71,000 | +26.8% |
| FY2024 | $56,000 | -60.0% |
| FY2023 | $140,000 | — |
| FY2022 | $0 | — |
| FY2021 | $0 | -100.0% |
| FY2020 | $46,000 | -85.0% |
| FY2019 | $306,000 | -30.3% |
| FY2018 | $439,000 | +1.9% |
| FY2017 | $431,000 | -89.9% |
| FY2016 | $4.3M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice